Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.

Yang, Wuping; Zhou, Jingcheng; Zhang, Kenan; Li, Lei; Xu, Yawei; Ma, Kaifang; Xie, Haibiao; Cai, Lin; Gong, Yanqing; Gong, Kan

Yang, Wuping; Zhou, Jingcheng; Zhang, Kenan; Li, Lei; Xu, Yawei; Ma, Kaifang; Xie, Haibiao; Cai, Lin; Gong, Yanqing; Gong, Kan.

Afiliação

Yang W; Department of Urology, Peking University First Hospital, Beijing 100034, P.R. China.
Zhou J; Hereditary Kidney Cancer Research Center, Peking University First Hospital, Beijing 100034, P.R. China.
Zhang K; Institute of Urology, Peking University, Beijing 100034, P.R. China.
Li L; National Urological Cancer Center, Beijing 100034, P.R. China.
Xu Y; Department of Urology, Peking University First Hospital, Beijing 100034, P.R. China.
Ma K; Hereditary Kidney Cancer Research Center, Peking University First Hospital, Beijing 100034, P.R. China.
Xie H; Institute of Urology, Peking University, Beijing 100034, P.R. China.
Cai L; National Urological Cancer Center, Beijing 100034, P.R. China.
Gong Y; Department of Urology, Peking University First Hospital, Beijing 100034, P.R. China.
Gong K; Hereditary Kidney Cancer Research Center, Peking University First Hospital, Beijing 100034, P.R. China.

J Cancer ; 12(9): 2702-2714, 2021.

Article em En | MEDLINE | ID: mdl-33854630

Palavras-chave

FGD5-AS1; VHL; ccRCC; lncRNAs; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Cancer Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google